Clinical Trials

Showing trials with last updates posted in 2020.

NCT01269385 | COMPLETED | PHASE1/PHASE2
22 participants

Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2020-06-23
Start Date:
2011-01-31
Completion:
2014-06-30
Conditions
  • B-cell Chronic Lymphocytic Leukemia
  • Refractory Chronic Lymphocytic Leukemia
  • Stage 0 Chronic Lymphocytic Leukemia
  • Stage I Chronic Lymphocytic Leukemia
  • Stage II Chronic Lymphocytic Leukemia
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
  • GENETIC
Previous
Sorted by latest updates
Next
Showing 40 trials per page